Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage

Pertussis Pathogenesis--What We Know and What We Don't Know

(2014) E. L. Hewlett et al.   JOURNAL OF INFECTIOUS DISEASES

Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States

(2013) L. C. Pawloski et al.   Clinical and Vaccine Immunology

Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin

(2013) F. R. MOOI et al.   EPIDEMIOLOGY AND INFECTION

Pertactin-negative variants of Bordetella pertussis in New York State: A retrospective analysis, 2004–2013

(2013) Tammy Quinlan et al.   MOLECULAR AND CELLULAR PROBES

Pertactin-Negative Variants of Bordetella pertussis in the United States

(2013) Anne Marie Queenan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Priming with Whole-Cell versus Acellular Pertussis Vaccine

(2013) Juventila Liko et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers

(2013) N. P. Klein et al.   PEDIATRICS

Waning Immunity to Pertussis Following 5 Doses of DTaP

(2013) S. Y. Tartof et al.   PEDIATRICS

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

(2013) J. M. Warfel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Appearance of Bordetella pertussis Strains Not Expressing the Vaccine Antigen Pertactin in Finland

(2012) Alex-Mikael Barkoff et al.   Clinical and Vaccine Immunology

Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin

(2012) N. Hegerle et al.   CLINICAL MICROBIOLOGY AND INFECTION

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

(2012) Sarah L. Sheridan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010

(2012) Lara K. Misegades et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America

(2012) D. Bottero et al.   JOURNAL OF APPLIED MICROBIOLOGY

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

(2012) Nicola P. Klein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan

(2012) Nao Otsuka et al.   PLoS One

Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries

(2011) Teemu Kallonen et al.   INFECTION GENETICS AND EVOLUTION

Bordetella parapertussis isolates not expressing pertactin circulating in France

(2010) V. Bouchez et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pertactin Is Required for Bordetella Species To Resist Neutrophil-Mediated Clearance

(2010) C. S. Inatsuka et al.   INFECTION AND IMMUNITY

First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin

(2009) V. Bouchez et al.   VACCINE

Genomic Content of Bordetella pertussis Clinical Isolates Circulating in Areas of Intensive Children Vaccination

(2008) Valérie Bouchez et al.   PLoS One